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Abstract
Malfunction of the SLC26A4 protein leads to Pendred
syndrome, characterized by sensorineural hearing
loss, often associated with mild thyroid dysfunction
and goiter. It is generally assumed that SLC26A4 acts
as a chloride/anion exchanger, which in the thyroid
gland transports iodide, and in the inner ear contrib-
utes to the conditioning of the endolymphatic fluid.
Here we describe a fast fluorometric method able to
be used to functionally scrutinize SLC26A4 and its
mutants described in Pendred syndrome. The vali-
dation of the method was done by functionally char-
acterizing the chloride/iodide transport of SLC26A4,
and a mutant, i.e. SLC26A4S28R, which we previously
described in a patient with sensorineural hearing loss,
hypothyroidism and goiter. Using the fluorometric
method we describe here we can continuously moni-
tor and quantify the iodide or chloride amounts trans-
ported by the cells, and we found that the transport
capability of the SLC26A4S28R mutant protein is mark-





























Functional studies scrutinizing the anion transport
activity of the SLC26A4 protein and its mutants are ham-
pered by the use of radioactive uptake-studies. Two iso-
topes are commonly used in these studies, i.e. chloride
(36Cl-)[1-3], whose low specific activity leads to techni-
cal limitations, or iodide (125I-) [4-7].
In order to measure SLC26A4 anion exchange ac-
tivity, without the need of radioisotopes, we applied an
easy to use, nowadays readily available and fast
fluorometric method that has been used previously for
the characterization of CFTR induced chloride movements
across the cellular membrane [8].
It has been demonstrated that SLC26A4 can ex-
change anions as different as Cl-, HCO3-, OH-, I-, or for-
mate [9]. The SLC26A4 protein is mainly expressed in
the inner ear, the kidney, and the thyroid gland. In the
inner ear, the SLC26A4 protein is involved in the condi-
tioning of the endolymphatic fluid, most likely by acting
as an anion transporter [10].
In the kidney, SLC26A4 is located in the apical mem-
brane of β-intercalated cells [11]. There, SLC26A4 seems
to be involved, amongst other important transporters like
AE1 and AE4 [12, 13], in bicarbonate transport. In the
thyroid gland, SLC26A4 is expressed in the thyrocytes,
where it has been shown that SLC26A4 resides in the
apical membrane [14]. This membrane is facing the
follicular lumen into which the exchanger transports io-
dide, which then will be organified on thyroglobulin [15].
The malfunction of the SLC26A4 protein leads to
the Pendred syndrome (PS; OMIM 274600). Pendred
syndrome is considered one of the most common forms
of syndromic deafness accounting for up to 7.5% of
cases of childhood deafness [16]. More than 150 differ-
ent mutations of the SLC26A4 gene have been found in
humans so far (www.medicine.uiowa.edu/
pendredandbor). Clinically, the patients have severe or
profound sensorineural hearing loss, associated with en-
largement of the vestibular aqueduct and of the
endolymphatic duct and sac [17]. The hearing symptoms
are associated with positive perchlorate test, whereas
goiter and hypothyroidism can be diagnosed in about half
of the cases [18]. Since the modified anion exchange
capability of the mutated SLC26A4 proteins in patients
suffering of PS can explain the observed pathological
phenotypes, the development of an easy-to-use technique
able to quantify the SLC26A4 transport capability is of
utmost importance. Here we show a fast and easy-to-
use fluorometric method able to disclose hampered
SLC26A4 chloride/iodide exchange.
Materials and Methods
Cloning of SLC26A4 cDNA
Standard procedures were used for DNA prepara-
tion, cloning, purification, and sequencing. The human wild-
type SLC26A4 cDNA was obtained by RT-PCR, using
total RNA from normal human thyroid tissue and Taq
PLATINUM Pfx DNA polymerase (Invitrogen,-Life
Technologies). The SLC26A4 open reading frame was
cloned into pTARGET vector, where six histidines were
added to the C-terminus of SLC26A4 for localizing the
overexpressed protein by using anti-His-tag antibodies.
For this procedure the primer-pairs were: sense, 5’-GTT
GGA TCC GCG AGC AGA GAC AGG TCA-3’;
antisense, 5’-CTG CGC GGC CGC TCA GTG GTG
GTG GTG GTG GTG GGA TGC AAG TGT ACG CAT
A -3’. The primers contained appropriate linkers for clon-
ing the SLC26A4 cDNA into the BamH I and Not I sites
of the pTARGET plasmid (Promega).
Mutagenesis
The SLC26A4S28R mutant was made using the Quik
Change site-directed mutagenesis kit (Stratagene) ac-
cording to the manufacturer’s protocol, using the follow-
ing primers: sense 5'-CGG CCG GTC TAC AGA GAG
CTC GCT TTC CA-3'; antisense 5'-TGG AAA GCG
AGC TCT CTG TAG ACC GGC CG-3'. The mutant
was fully sequenced before testing at the functional level.
Cell culture and transient transfection
HEK 293 Phoenix cells (this is a second generation
retrovirus producing cell line for the generation of helper
free ectopic and amphotropic retroviruses; [19]) were
grown in Minimum Essential Medium Eagle (Sigma) sup-
plemented with 10% foetal bovine serum (Cambrex
BioScience), 2 mM L-glutamine, 100 units/ml penicillin,
100 µg/ml streptomycin, 1 mM pyruvic acid (sodium salt).
The cells were maintained at 37°C in a 5%CO2: 95% air
humidified incubator; subcultures were routinely estab-
lished every second to third day seeding cells in Petri
dishes after trypsin/EDTA treatment.
Fluorescence measurements
A) Chloride and iodide measurements. For in vivo
fluorometric chloride/iodide measurements, HEK 293
Phoenix cells grown on coverslips (∅ 40 mm) were
































method) with the vector pEYFP-N1 coding for a modi-
fied YFP protein (EYFP), which can be used for meas-
uring the intracellular halide amount (Clontech, CA, USA)
[20]. For this, 3 µg of pEYFP plasmid dissolved in 175 µl
H2O were mixed with 25 µl of buffer A (CaCl2 2 M), and
200 µl of buffer B (140 mM NaCl, 1,5 mM Na2HPO4, 50
mM HEPES, pH 7 adjusted with NaOH) and then added
to each coverslip. For measuring the halide (chloride and
iodide) effects on cells expressing pendrin or its mutants,
cells were co-transfected with 2 µg of pEYFP-N1 and
the pTARGET (6 µg) plasmid bearing the cDNA of the
respective SLC26A4 protein, i.e. wild-type SLC26A4 or
SLC26A4S28R. The experiments were performed 24-48
hours after transfection.
For the chloride/iodide titration experiments (figure
Fig. 1. The EYFP signal is
sensitive to chloride and io-
dide. Fluorescence measure-
ments in HEK 293 Phoenix
cells transfected with EYFP
and exposed to different chlo-
ride, as well as iodide solu-
tions in the presence of
nigericin and tributyltin chlo-
ride (both 10 µM). Since the
halides quench the EYFP sig-
nal, their increased concentra-
tion leads to a diminished fluo-
rescence signal. A) Fluores-
cence measurements in the
presence of increasing chlo-
ride concentrations (from
0 mM to 150 mM; the dashed
lines indicate the respective
changes of the extracellular
chloride or iodide concentra-
tions). B) Fluorescence meas-
urements in the presence of
increasing iodide concentra-
tions (from 0 mM to 150 mM).
Compared to chloride, iodide
is able to quench the EYFP
fluorescence more efficiently,
leading to a more pronounced decrease of the fluorescence signal at the respective iodide concentrations if compared to chloride
(1A). C) Summary of the experiments shown in A and B. Fluorescence intensities are normalized in order to give a value, in the
absence of chloride or iodide, equal to 100%. The data points are well fitted (r2 = 0.98 for chloride and r2= 0.99 for iodide) with an
one phase decay exponential equation (see methods) with the following parameters for chloride and iodide, respectively: α=
58,42±1,5 and 86,83±0,37; β = 42,72±1.13 and 8,824±0.39; K = 0,02409±0,0016 and 0,01757±0,00024 (n = 4). The line indicates the
respective relative fluorescence intensity at an intracellular halide concentration of 43 mM, which is the intracellular chloride
concentration according to panel D. Due to the fact that iodide is a better quencher of the EYFP signal compared to chloride, at
the same halide concentration the relative fluorescence given by iodide is 14% lower compared to chloride (solid part of the line).
D) Normalized relative fluorescence intensity given by HEK cells in the presence of “high Cl-“ (see method) and after omitting the
extracellular chloride. According to panel C the 63% relative fluorescence amounts to 43 mM intracellular chloride.
1) needed for the quantification of the halides signals,
HEK 293 Phoenix cells transiently transfected with
pEYFP-N1 were perfused in a laminar-flow chamber
(FCS2 System, Bioptechs, USA) at 0,3 ml/min (room tem-
perature) and EYFP fluorescence changes (excitation at
515 nm; emission at 525-600 nm) were measured in the
presence of (i) different concentrations of Cl- or I- (0, 10,
25, 50 and 150 mM respectively; in order to avoid changes
in the osmolality, potassium gluconate was added accord-
ingly), (ii) nigericin (10 µM), (iii) tributyltin chloride (10
µM), and (iv) high potassium (150 mM), in order to allow
equilibration of the intracellular and extracellular halides
concentrations, to avoid pH variations and to dissipate
the membrane potential. The relative fluorescence
intensities at the different chloride (figure 1a) or iodide




























(figure 1b) concentrations are summarized in figure 1c,
and best fitted by an one phase decay exponential equa-
tion:
EQ1
where Frel is the measured relative fluorescence in-
tensity (%), [x] is the halide concentration (mM) and α,
β and K are the fitting parameters. Figure 1d shows the
measurement of Frel at “high Cl-“ (see below) and after
omitting chloride from the extracellular solution. The Frel
under “high Cl-“ amounts to 63 ± 0.6 % (n=14), which
corresponds, according to equation 1 (EQ1), to an intra-
cellular chloride concentration of     43 mM (figure 1c),
which is in good agreement with the 45 ± 4 mM reported
by Gillen and Forbush [21].
In experiments aimed to evaluating the pendrin in-
duced halide transport, HEK 293 Phoenix cells co-
transfected with pEYFP-N1 and the pTARGET plasmid
bearing the respective SLC26A4 cDNA were continu-
ously superfused with “high Cl-“ (in mM: KCl 2, NaCl
135, CaCl2 1, MgCl2 1, D-glucose 10, HEPES 20, pH
7,4), or ”high I-“ (in mM: KCl 2, NaI 135 mM, MgCl2 1,
CaCl2 1, D-glucose 10, HEPES 20, pH 7,4) solutions.
The EYFP fluorescence measurements were performed
using a Leica TCS SP2 AOBS confocal microscope
(Leica Microsystem, Heidelberg, Germany), using a 515
nm Ar/ArKr laser line for exciting the EYFP fluores-
cence. Transfection efficiency was determined by im-
munocytochemistry, counting the cells expressing EYFP
and pendrin or its mutant in respect to the cells express-
ing only EYFP (for SLC26A4 the co-transfection effi-
cacy was 79.0 ±2.5 %, n=7, and for SLC26A4S28R the
co-transfection efficacy was 73.4 ± 4.2 %, n=7; both
values are not statistically different from each other).
B) pH measurements. For intracellular pH meas-
urements the fluorescent indicator BCECF (2’,7’-bis-(2-
carboxyethyl)-5-(and-6)-carboxyfluorescein) was used.
HEK 293 Phoenix cells were transiently transfected with
pTARGET-SLC26A4 plasmid and loaded (30 min, 37 °C)
with 1,5 mM BCECF-AM (acetoxymethyl ester). BCECF
fluorescence was excited using a 488 nm and a 458 Ar/
ArKr laser lines during the continuous perfusion of the
cells with the “high Cl-“ or the “high I-” solutions (emis-
sion intensity evaluated at 535 ±20 nm; experiments were
performed at RT). Intracellular pH was calculated fol-
lowing the standard ratiometric method (http://
probes.invitrogen.com/media/pis/mp01150.pdf). Titration
of the intracellular pH was performed in nigericin (10
µM) treated HEK 293 Phoenix cells in presence of 130
mM potassium (KCl 130 mM, MgCl2.6H2O 1 mM,
HEPES 30 mM, mannitol 20 mM), at pH’s of 5.0 ,7.0
and 7.4.
Immunocytochemistry
For the immunofluorescence assays, cells were
probed 32 hours after double transfection with pTARGET-
SLC26A4 or pTARGET-SLC26A4S28R and pEYFP-N1
plasmid (3:1 ratio). Cells were washed with 2 ml PBS at
room temperature, fixed for 15 min in 3%
paraformaldehyde, permeabilized for 3 min with 0.1%
Triton X-100 and blocked 1 hour at room temperature in
PBS/3% BSA. Coverslips were incubated overnight at
4°C with an anti His-tag mouse monoclonal antibody
(Roche; Germany), diluted 1:100 in PBS/0.1% BSA, rec-
ognized by an Alexa Fluor 568 coupled goat anti-mouse
secondary antibody (diluted 1:200 in PBS/ 0.1% BSA, 1
hour incubation at room temperature).
Chemicals
All chemicals used are of analysis grade.
Statistical Analyses
Data are expressed as arithmetic means ± S.E. Sta-
tistical analysis was performed using the one way
ANOVA with Bonferroni’s multiple comparison test. Sta-
tistically significant differences were assumed at p < 0.05.
Results and Discussion
The EYFP signal is able to reveal changes in the
intracellular chloride concentrations
Recently, variants of the yellow fluorescent protein
(YFP) from Aequorea have been successfully used as a
new class of biocompatible fluorescent dyes, sensitive
for halides [8, 20, 22-26]. In the present study we use a
readily available enhanced YFP protein as an indicator
for the intracellular halide amount (EYFP; pEYFP-N1,
Clontech) [20].
In a first set of experiments, we verified whether
HEK 293 Phoenix cells expressing EYFP are sensitive
to changed intracellular chloride and iodide concentra-
tion. For this we incubated EYFP expressing cells with
the anion ionophore tributyltin [27] and changed the ex-
tracellular chloride or iodide concentration in the pres-
ence of high potassium and nigericin in order to avoid pH
variations and to dissipate the membrane potential, which
affects the passive anion distribution across the cell mem-
brane. As shown in figure 1a and b, cells were kept in a
solution void of chloride or iodide (0 mM). Increasing the
































extracellular chloride or iodide concentration stepwise to
150 mM leads to a substantial and reversible (not shown)
decrease of the EYFP fluorescence, which is more pro-
nounced in the iodide experiments if compared to chlo-
ride (figure 1c). These experiments indicate that the EYFP
we use has a higher affinity for iodide if compared to
chloride, which is in agreement with the halide sensitivity
of an other variant of EYFP, i.e. I - > SCN- > NO3 > Cl
-
> Br- [8, 22].
HEK cells expressing SLC26A4 show a marked
halide transport activity
In order to test the halide transport activity of ex-
pressed SLC26A4 we measured the EYFP fluorescence
before and after substituting extracellular chloride by io-
Fig. 2. HEK 293 Phoenix cells expressing SLC26A4 transport
I-. A) EYFP fluorescence (F) measured in HEK 293 Phoenix cells
co-transfected with EYFP and SLC26A4 (SLC26A4) or with
EYFP and the empty plasmid (control), and exposed to the
“high Cl-“ or the “high I-” solutions. Only cells transiently
transfected with SLC26A4 respond to the change in extracellu-
lar I- concentration with a decrease in intracellular fluorescence,
evidencing a I-/Cl- exchange. Dashed lines indicate the respec-
tive changes of the extracellular solutions. B) The ROI (region
of interest) used for the calculation of the mean fluorescence
of the SLC26A4 trace shown in A).
Fig. 3. Measurements of the intracellular pH by using BCECF.
A) Original tracing showing the emission at the two wave-
lengths (488 nm and 458 nm) after changing the extracellular
chloride (“high Cl-“) to iodide (“high I-“). B) The ratio of the
two wavelengths showing that the intracellular pH does not
change during the exchange of the extracellular halides.
dide. The SLC26A4 protein is able to transport chloride
[1-3] as well as iodide [4-7, 28], and therefore, since io-
dide is a much better EYFP quencher than chloride, an
increase of intracellular iodide should lead to a decrease
of EYFP fluorescence [8]. Indeed, as shown in figure 2,
substituting 135 mM of chloride by the same amount of
iodide leads to a marked and reversible decrease of EYFP
fluorescence in cells expressing SLC26A4 by -17.98 ±
3.53 % (n=8), considering the starting level of the rela-
tive fluorescence in those experiments as 100%. How-
ever, if the fluorescence in the absence of chloride is
considered as 100%, then the observed -17.98% amounts
to -11.31 ± 2.22% (n=8). It is interesting that the ob-
served reduction of the fluorescence is indicating that
chloride and iodide are exchanged in a 1:1 way by the




























Fig. 4. HEK 293 Phoenix cells express-
ing SLC26A4S28R have an impaired I-
transport. Relative fluorescence inten-
sity obtained in fields of about 10-20
cells and measured in HEK 293 Phoenix
cells co-transfected with EYFP and
pTARGET-SLC26A4 (n=3), pTARGET-
SLC26A4S28R (n=3) or the empty (n=4)
plasmids and exposed to the “high Cl-“
or the “high I-” solutions. SLC26A4S28R
transfected cells behave as the control
cells. The dashed lines indicate the re-
spective changes of the extracellular
solutions.
Fig. 5. ROI and whole-field fluorescence measure-
ments. A) Maximal fluorescence % variation after the
ionic substitution calculated as average of different
ROIs inside the cells (Cl- substituting for I-: control
n= 8, SLC26A4 n= 10, SLC26A4S28R n=7; I- substitut-
ing for Cl-: control n= 8, SLC26A4 n= 8, SLC26A4S28R
n=7). B) Maximal fluorescence % variation per minute
(∆F/dt) after the ionic substitution calculated as av-
erage of single ROI’s inside the cells (Cl- substitut-
ing for I-: control n= 13, SLC26A4 n= 8, SLC26A4S28R
n=7; I- substituting for Cl-: control n= 7, SLC26A4 n=
8, SLC26A4S28R n=7). C) Maximal fluorescence % vari-
ation calculated as average of different fields of about
10-20 cells (control n= 4, SLC26A4 n= 3, SLC26A4S28R
n=3). In every panel the maximal fluorescence varia-
tion of the SLC26A4 is significantly different from
the SLC26A4S28R and from the control.
transporter. The evidence for that is seen in figure 1c. As
explained in the former chapter, the two curves shown in
figure 1c indicate the reduced fluorescence of EYFP at
increasing intracellular chloride as well as iodide concen-
trations. The relative fluorescence level obtained under
“high Cl-“ is, as mentioned above, 63% (figure 1d), which
corresponds to an intracellular chloride concentration of
43 mM (figure 1c). If the exchanger works in a 1:1 cou-
pling-ratio then we should expect a decrease of the fluo-
rescence by exchanging chloride with iodide of 14%,
which is not statistically different from the observed -
11.31% mentioned above. In control cells not
overexpressing SLC26A4, the exchange of extracellular
chloride with iodide leads to a significantly smaller de-
crease of the relative fluorescence of -3.33 ± 0.55% (n=8;
































under “high Cl-“ as 100%), pointing to the fact that trans-
porters or channels able to pass iodide from the extracel-
lular space towards the cytosol are scarcely active in the
native HEK 293 Phoenix cell line we use. This cell line is
therefore particularly suited to test SLC26A4 induced
halide transport activity after overexpressing the respec-
tive proteins. Since EYFP is also sensitive to pH [8, 29-
31], in order to exclude any unpredictable pH changes
under the conditions we chose for our experiments, we
made control experiments measuring the intracellular pH
by measuring the BCECF fluorescence (figure 3). The
intracellular pH at “high Cl-“ is 6.91 ± 0.01 (n=8) and
does not change significantly after changing the extra-
cellular solution to “high I-“ (∆pH = 0.01 ± 0.01; n=8) and
again back to “high Cl-“ (∆pH = 0.01 ± 0.01; n=8). These
results indicate that using the conditions we described,
neither HCO3- nor OH- is substantially transported by
SCL26A4 expressing cells.
The halide transport evidenced by the EYFP fluo-
rescence is annihilated in cells expressing a
SLC26A4 mutant
Recently we identified a mutant of SLC26A4, i.e.
SLC26A4S28R, in a patient with sensorineural hearing loss,
hypothyroidism and goiter [32]. We demonstrated that
this mutant can be expressed in HEK 293 Phoenix cells
and is translocated towards the cellular membrane, how-
ever, the chloride transport evidenced by radioactive up-
take-studies revealed an impaired function [2]. We used
the same mutant of SLC26A4 in order to validate the
EYFP-fluorometric method described here. As can be
seen in figure 4, the marked change in EYFP fluores-
cence measured after exchanging chloride for iodide in
cells expressing SLC26A4 is abolished in cells express-
ing SLC26A4S28R, and therefore indistinguishable from
the effect seen in control cells. The lost effect in
SLC26A4S28R expressing cells is not due to a lacking trans-
position of the transport-protein towards the cellular mem-
brane, as it was described for several SLC26A4 mutants
[6]. As mentioned above, we have shown earlier that
SLC26A4S28R is indeed transposed towards the membrane
[2].
The fluorescence measurements shown in figures
1-2 were made using a region-of-interest (ROI) within
single cells. These experiments are summarized in figure
5a. The data reported in figure 5a are taken after steady
state conditions, however, as can be seen in figure 5b,
qualitatively the same results can be obtained one minute
after switching to the respective solutions under the dif-
ferent conditions tested, underlining the robustness of the
EYFP fluorescence measurements in the context of
SLC26A4 chloride/iodide transport testing. However, as
expected, the absolute values after one minute are smaller
if compared to the steady state conditions summarized in
figure 5a. It is, however, not essential to use ROI’s for
the measurements. As evidenced in figure 5c, also whole
field measurements reveal the observed differences be-
tween native SLC26A4 and the SLC26A4S28R mutant,
and are therefore suitable for scrutinizing SLC26A4 de-
pendent chloride/iodide transport in HEK 293 Phoenix
cells.
Conclusions
The SLC26A4 protein is a chloride/anion exchanger
capable of transporting also iodide. Malfunction of the
protein leads to Pendred syndrome, a disease-complex
characterized by deafness and impaired iodide
organification. Here, we show, an easy to use and fast
fluorometric method able to substantiate the chloride/io-
dide transport of SLC26A4. It is important to note that
the use of a confocal microscope as described here, is
not a prerequisite and that also more readily available
fluorescence imaging devices can be used. Furthermore,
we show for the first time that, by using this method, it is
possible to determine functional deterioration of the
SLC26A4 mutant (SLC26A4S28R) we described previ-
ously, showing that its transport capacity (chloride/iodide
exchange) is markedly reduced compared to wild-type
SLC26A4, consistent with the clinical phenotype observed
in the patient. In addition, we show that by titrating the
cellular model system either with chloride or iodide, and
measuring the respective fluorescence values allows, by
using a simple exponential fit, to determine the time-course
of intracellular halide concentrations. Therefore, the
fluorometric method we describe here can be used for
screening SLC26A4 mutants expressed in HEK 293
Phoenix cells, without the need of cumbersome and diffi-
cult to use radioactive uptake studies.
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